blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1504124

EP1504124 - LDL RECEPTOR-RELATED PROTEINS 1 AND 2 AND TREATMENT OF BONE OR CARTILAGE CONDITIONS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  05.08.2011
Database last updated on 14.09.2024
Most recent event   Tooltip05.08.2011Refusal of applicationpublished on 07.09.2011  [2011/36]
Applicant(s)For all designated states
Cornish, Jillian
60 B Godden Crescent Mission Bay
Auckland / NZ
For all designated states
Reid, Ian Reginald
7 Maybeck road Mount Albert
Auckland / NZ
For all designated states
Palmano, Kay Patricia
85 Buick Crescent
Palmerston North / NZ
For all designated states
Grey, Andrew Bevis
26 Seascape road Remuera
Auckland / NZ
For all designated states
Naot, Dorit
75 Avonleigh road Green Bay
Auckland / NZ
[N/P]
Former [2005/26]For all designated states
Cornish, Jillian
60 B Godden Crescent
Mission Bay, Auckland / NZ
For all designated states
Reid, Ian Reginald
7 Maybeck road
Mount Albert, Auckland / NZ
For all designated states
Palmano, Kay Patricia
85 Buick Crescent
Palmerston North / NZ
For all designated states
Grey, Andrew Bevis
26 Seascape road
Remuera, Auckland / NZ
For all designated states
Naot, Dorit
75 Avonleigh road
Green Bay, Auckland / NZ
Former [2005/06]For all designated states
Cornish, Jillian
23 Joseph Banks Terrace
Newmarket, Auckland / NZ
For all designated states
Reid, Ian Reginald
7 Maybeck road
Mount Albert, Auckland / NZ
For all designated states
Palmano, Kay Patricia
85 Buick Crescent
Palmerston North / NZ
For all designated states
Grey, Andrew Bevis
26 Seascape road
Remuera, Auckland / NZ
For all designated states
Naot, Dorit
75 Avonleigh road
Green Bay, Auckland / NZ
Inventor(s)01 / see applicant
...
 [2005/06]
Representative(s)Walker, Ross Thomson, et al
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2006/41]Walker, Ross Thomson, et al
Forrester & Boehmert, Pettenkoferstrasse 20-22
80336 München / DE
Former [2005/06]Brown, John David, et al
FORRESTER & BOEHMERT Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date03728178.913.05.2003
[2005/06]
WO2003NZ00087
Priority number, dateUS20020380227P13.05.2002         Original published format: US 380227 P
US20030463419P16.04.2003         Original published format: US 463419 P
[2005/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03095678
Date:20.11.2003
Language:EN
[2003/47]
Type: A1 Application with search report 
No.:EP1504124
Date:09.02.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2003 takes the place of the publication of the European patent application.
[2005/06]
Search report(s)International search report - published on:AU20.11.2003
(Supplementary) European search report - dispatched on:EP27.07.2006
ClassificationIPC:C12Q1/68, C07K14/71, G01N33/53
[2005/06]
CPC:
C07K14/705 (EP,US); A61P1/16 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P13/12 (EP); A61P19/00 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P21/02 (EP);
A61P25/08 (EP); A61P29/00 (EP); A61P3/12 (EP);
A61P3/14 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P5/18 (EP); A61P5/46 (EP); G01N33/92 (EP,US);
G01N2500/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/06]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:LDL-REZEPTOR-VERWANDTE PROTEINE 1 UND 2 UND BEHANDLUNG VON KNOCHEN- ODER KNORPELERKRANKUNGEN[2005/06]
English:LDL RECEPTOR-RELATED PROTEINS 1 AND 2 AND TREATMENT OF BONE OR CARTILAGE CONDITIONS[2005/06]
French:PROTEINES 1 ET 2 ASSOCIEES AUX RECEPTEURS DES LIPOPROTEINES DE FAIBLE DENSITE (LDL) ET TRAITEMENT DE PATHOLOGIES OSSEUSES OU CARTILAGINEUSES[2005/06]
Entry into regional phase26.11.2004National basic fee paid 
26.11.2004Search fee paid 
26.11.2004Designation fee(s) paid 
26.11.2004Examination fee paid 
Examination procedure05.11.2003Request for preliminary examination filed
International Preliminary Examining Authority: AU
26.11.2004Examination requested  [2005/06]
17.01.2005Amendment by applicant (claims and/or description)
09.06.2008Despatch of a communication from the examining division (Time limit: M06)
23.01.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
02.04.2009Reply to a communication from the examining division
17.03.2011Application refused, date of legal effect [2011/36]
17.03.2011Cancellation of oral proceeding that was planned for 17.03.2011
17.03.2011Date of oral proceedings (cancelled)
08.04.2011Despatch of communication that the application is refused, reason: substantive examination [2011/36]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.06.2008
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
02.04.2009Request for further processing filed
02.04.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
12.05.2005Renewal fee patent year 03
10.05.2006Renewal fee patent year 04
14.05.2007Renewal fee patent year 05
14.05.2008Renewal fee patent year 06
12.05.2009Renewal fee patent year 07
17.08.2010Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.201008   M06   Fee paid on   17.08.2010
31.05.201109   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]JPH07138188  ;
 [X]WO0076552  (BAYLOR COLLEGE MEDICINE [US]) [X] 1-18 * the whole document *;
 [X]WO0157266  (HYSEQ INC [US], et al) [X] 1-18 * abstract * * pages 54-56 *;
 [X]WO0192474  (UNIV CONNECTICUT HEALTH CT [US]) [X] 1-18 * abstract * * page 7 * * pages 12-13; claims 1-12,96 *;
 [A]WO0216553  (AVENTIS PHARMA SA [FR], et al) [A] 1-18 * the whole document *;
 [E]WO03106657  (STOWERS INST FOR MEDICAL RES [US]) [E] 1-18 * the whole document *;
 [E]WO2004033657  (ANTIGENICS INC [US], et al) [E] 1-18 * the whole document *;
 [X]  - "Oral compsn. for treatment of parodontosis - comprises alpha-2-macro:globulin, to inhibit bone resorption due to endotoxin of pathogenic bacteria of parodontosis", DATABASE WPI, 0, Derwent World Patents Index, vol. 1995, no. 30, Database accession no. 1995-228641, XP002376839 & JPH07138188 A 19950530 ((LIOY ) LION CORP) [X] 1-18 * column A *
 [A]  - STRICKLAND DUDLEY K ET AL, "Diverse roles for the LDL receptor family.", TRENDS IN ENDOCRINOLOGY AND METABOLISM, (200203), vol. 13, no. 2, ISSN 1043-2760, pages 66 - 74, XP002376834 [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1043-2760(01)00526-4
 [T]  - GREY ANDREW ET AL, "The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells", MOLECULAR ENDOCRINOLOGY, (200409), vol. 18, no. 9, ISSN 0888-8809, pages 2268 - 2278, XP002376835 [T] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1210/me.2003-0456
 [T]  - CORNISH J ET AL, "Lactoferrin and bone: an overview of recent progress", AUSTRALIAN JOURNAL OF DAIRY TECHNOLOGY, (200504), vol. 60, no. 1, ISSN 0004-9433, pages 53 - 57, XP009065252 [T] 1-18 * the whole document *
 [T]  - NIEMEIER ANDREAS ET AL, "Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro", ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, (199903), vol. 19, no. 3, ISSN 1079-5642, pages 552 - 561, XP009065102 [T] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1359/JBMR.041102
International search[X]WO0203985  (UNIV SAINT LOUIS [US], et al);
 [A]  - KATO M. ET AL., "Cbfa1-independent decrease in osteoblast proliferation, osteopenia and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor", JOURNAL OF CELL BIOLOGY, (20020415), vol. 157, pages 303 - 314, XP008070712

DOI:   http://dx.doi.org/10.1083/jcb.200201089
 [A]  - LITTLE R.D. ET AL., "A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait", AMERICAN JOURNAL OF HUMAN GENETICS, (200201), vol. 70, pages 11 - 19, XP002287932

DOI:   http://dx.doi.org/10.1086/338450
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.